Etizolam
Etizolam is a thienodiazepine — a benzodiazepine analogue in which the benzene ring is replaced by a thiophene ring. It is a licensed medicine in Japan, Italy and India for anxiety and short-term insomnia, but elsewhere it circulates as an unregulated research chemical and is widely misused. It produces the familiar benzodiazepine profile of anxiolysis, sedation and muscle relaxation, with rapid onset and a relatively short half-life that encourages redosing.
01 Overview
Etizolam acts at the same GABA-A benzodiazepine site as diazepam and is roughly comparable to it in potency on a milligram basis, though users often report a stronger hypnotic and euphoric character. Because it is a genuine pharmaceutical in a few countries, more human data exist than for most designer benzodiazepines, but formal characterisation of misuse outside therapeutic settings remains thin and rests largely on case reports and poison-centre data.
The main harms are dependence and withdrawal, dangerous potentiation with other central nervous system depressants, and profound amnesia at higher doses. Etizolam has featured heavily in adulterated street 'benzo' tablets and in polydrug deaths, typically in combination with opioids or alcohol where the combined respiratory depression is the proximate cause of death.
02 Mechanism
Positive allosteric modulator of the GABA-A receptor at the benzodiazepine site, enhancing chloride conductance and neuronal inhibition. The thiophene ring substitution increases potency relative to classical benzodiazepines.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Threshold | 0.25–0.5 mg | Oral | Onset ~30-60 min. |
| Common | 0.5–1 mg | Oral | Roughly diazepam-equivalent on a mg basis. |
| Strong | 1–2 mg | Oral | Amnesia and heavy sedation likely; disinhibited redosing common. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| AnxiolysisReduction in anxiety and psychic tension, the primary therapeutic effect where it is licensed. | Observational | ||
| Sedation and muscle relaxationDrowsiness, hypnotic effect and skeletal muscle relaxation. | Observational | ||
| Euphoria and disinhibitionUsers frequently report a mild euphoria and loss of inhibition, a driver of recreational misuse. | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Anterograde amnesia and blackoutsHigher doses commonly produce memory gaps and blackout behaviour with impaired judgement. | Moderate | Common at higher doses | Anecdotal | |
| Physical dependence and withdrawalRegular use produces tolerance and physical dependence; abrupt cessation can cause rebound anxiety, insomnia, tremor and seizures. Cross-tolerance with all benzodiazepines means a benzodiazepine habit is effectively continued. | Severe | Universal with regular use | Observational | |
| Respiratory depression in combinationCombined with opioids, alcohol or other depressants, etizolam causes additive respiratory depression that is a frequent cause of death in reported fatalities. | Life-threatening | Common in polydrug use | Observational |